Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health, under the provisions of section 24 (5) of the Act, and are set out in the Schedule hereto:
Schedule
Product: Sandostatin
Active Ingredient(s): Octreotide 0.05mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer(s): Novartis Pharma AG, Basel, Switzerland
Product: Sandostatin
Active Ingredient(s): Octreotide 0.1mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer(s): Novartis Pharma AG, Basel, Switzerland
Product: Sandostatin
Active Ingredient(s): Octreotide 0.5mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer(s): Novartis Pharma AG, Basel, Switzerland
Dated this 7th day of March 2001.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).